Company registration number 09078349 (England and Wales)
BLUE BROGUE PHARM LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024
BLUE BROGUE PHARM LIMITED
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
BLUE BROGUE PHARM LIMITED
BALANCE SHEET
AS AT 30 JUNE 2024
30 June 2024
- 1 -
2024
2023
£
£
£
£
Fixed assets
1,028
817
Current assets
22,035
27,219
Creditors: amounts falling due within one year
(15,623)
(14,715)
Net current assets
6,412
12,504
Total assets less current liabilities
7,440
13,321
Creditors: amounts falling due after more than one year
(7,098)
(12,024)
Net assets
342
1,297
Capital and reserves
342
1,297
Notes to the financial statements
1
Director's benefits: advances, credit and guarantees

Mohammed Tahir

Balance outstanding at start of period        20,913

Amounts advanced                12,237

Amounts repaid                    15,000

Amounts written off                -

Amounts waived                    -

Balance outstanding at end of period        18,150

 

 

The loan was unsecured, interest charged at 2.25% and repayable on demand.

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2024
2023
Number
Number
Employees
2
2

Blue Brogue Pharm Limited is a private company limited by shares incorporated in England and Wales. The registered office is 16 Sycamore Crescent, Birmingham, UK, B24 8DF.

For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

BLUE BROGUE PHARM LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024
30 June 2024
- 2 -

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 18 March 2025
Mohammad Tahir
Director
Company registration number 09078349 (England and Wales)
2024-06-302023-07-01falseCCH SoftwareCCH Accounts Production 2024.100No description of principal activityMohammad Tahirfalsefalse090783492023-07-012024-06-30090783492024-06-30090783492023-06-3009078349core:CurrentFinancialInstrumentscore:WithinOneYear2024-06-3009078349core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-3009078349core:Non-currentFinancialInstruments2024-06-3009078349core:Non-currentFinancialInstruments2023-06-30090783492022-07-012023-06-3009078349bus:Director12023-07-012024-06-3009078349bus:PrivateLimitedCompanyLtd2023-07-012024-06-3009078349bus:SmallCompaniesRegimeForAccounts2023-07-012024-06-3009078349bus:Micro-entities2023-07-012024-06-3009078349bus:AuditExemptWithAccountantsReport2023-07-012024-06-3009078349bus:FullAccounts2023-07-012024-06-30xbrli:purexbrli:sharesiso4217:GBP